LifeCodexx Partners with QIAGEN to Improve the PrenaTest, Europe’s First Non-invasive Prenatal Test

In this video, Dr Stephan Busche, Laboratory Head at LifeCodexx AG, explains how protocols and kits from QIAGEN have made a pioneering pre-natal test possible. There is a 1% risk of procedure-related miscarriage, but this innovative method relying on prenatal DNA collected from the mother's blood hopes to remove the need for invasive pre-natal testing. Automating this liquid biopsy and Next Generation Sequencing (NGS)- based technique using the QIASymphony has increased throughput and improved reproducibility of the test.